Skip to main content

Oxford Nanopore Technologies: Tim Cowper, Jordan Herman

Tim Cowper has become CFO and Jordan Herman general counsel of Oxford Nanopore Technologies.

Chowper joined the company in 2012 as commercial operations director after acting as interim finance director for several months in 2009. He became VP of finance in 2017. Previously, he was finance director at British Biotech and at Clipper Ventures, he cofounded Sterilox, and he was financial controller at Celltech.

Herman joins Oxford Nanopore from Baker Botts, where he was a partner and acted as Oxford's outside counsel for more than a decade. He holds a JD from Ohio State University and a degree in political economy from Washington University.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.